timolol has been researched along with transforming growth factor beta in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Georgiadis, N; Karabatsas, CH; Koliakos, GG; Konstas, AG; Liakos, P; Ritch, R; Schlötzer-Schrehardt, U | 1 |
| Ibrahim, DG; Iwata, W; Kiuchi, Y; Ko, JA; Okumichi, H | 1 |
| Hirooka, K; Kiuchi, Y; Ko, JA; Komatsu, K; Kondo, S; Minamoto, A; Okumichi, H | 1 |
3 other study(ies) available for timolol and transforming growth factor beta
| Article | Year |
|---|---|
Latanoprost therapy reduces the levels of TGF beta 1 and gelatinases in the aqueous humour of patients with exfoliative glaucoma.
Topics: Adrenergic beta-Antagonists; Aged; Antihypertensive Agents; Aqueous Humor; Case-Control Studies; Gelatinases; Glaucoma; Humans; Latanoprost; Prostaglandins F, Synthetic; Timolol; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
An in vitro study of scarring formation mediated by human Tenon fibroblasts: Effect of Y-27632, a Rho kinase inhibitor.
Topics: Amides; Cicatrix; Collagen; Fibroblasts; Humans; Latanoprost; Pyridines; rho-Associated Kinases; Signal Transduction; Tenon Capsule; Timolol; Transforming Growth Factor beta | 2019 |
Effects of Ripasudil, a Rho-Kinase Inhibitor, on Scar Formation in a Mouse Model of Filtration Surgery.
Topics: Animals; Antiglaucoma Agents; Cicatrix; Collagen; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Latanoprost; Mice; Protein Kinase Inhibitors; rho-Associated Kinases; Timolol; Transforming Growth Factor beta; Vimentin | 2023 |